Bio Economy
The bio economy refers to the property production and conversion of biomass for a spread of food, health, fiber, and alternative industrial product yet as energy. The bio economy encompasses all industries and sectors manufacturing, managing or otherwise creating use of biological resources (including organic waste), like agriculture, forestry, and fisheries. The fashionable bio economy is based on data and innovation in biosciences, at the side of other technologies like engineering, chemistry, computing and nanotechnologies. The bio economy as a crucial component of the Strategy’s three main priorities of:
-
Smart growth: developing an information and innovation based economy, -
Sustainable growth: promoting tons of resource economical, greener and tons of competitive economy; -
Inclusive growth: fostering a high employment economy delivering social and territorial cohesion.
The global bio economy will grow from nearly 108.0 million tons in 2015 to 121.6 million tons by 2020 with a compound annual rate of growth (CAGR) of two .4% for the amount of 2015-2020.
- Medical Biotechnology
- Industrial Biotechnology
- Agricultural Biotechnology
Related Conference of Bio Economy
20th World Congress on Biomarkers, Cancer Therapy & Clinical Research
41st International Conference on Next-Gen Biotechnology and Applications
27th Global Summit on Analytical and Bioanalytical Techniques
Bio Economy Conference Speakers
Recommended Sessions
- Algal Biotechnology
- Animal Biotechnology
- Bio Economy
- Biomass and Bioenergy
- Biotechnology
- Biotechnology and Bioprocess Engineering
- Biotechnology Applications
- Biotechnology Enterprise and Entrepreneurship
- Biotechnology Products
- Cell/Molecular Biotechnology
- Environmental Biotechnology
- Food Biotechnology
- Genetic Engineering
- Marine Biotechnology
- Medical Biotechnology
- Nano Biotechnology
- Pharmaceutical Biotechnology
- Plant and Agriculture Biotechnology
- Stem Cell Biotechnology
- Systems and Synthetic Biotechnology
Related Journals
Are you interested in
- Advancements in Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Advancements in Biosimilar Development Technologies - Biosimilars 2026 (France)
- Advances in Genomic Biotechnology - Biotechnology 2025 (Spain)
- Analytical Challenges in Personalized Medicine - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in Agriculture - ANALYTICA ACTA 2026 (France)
- Analytical Chemistry in the Energy Sector - ANALYTICA ACTA 2026 (France)
- Analytical Techniques for Biotechnology - ANALYTICA ACTA 2026 (France)
- Analytical Techniques in Material Science - ANALYTICA ACTA 2026 (France)
- Artificial Intelligence and Digital Tools in Biotherapeutics - Biosimilars 2026 (France)
- Automation in Bioanalytical Laboratories - ANALYTICA ACTA 2026 (France)
- Bioanalytical Method Development and Validation - ANALYTICA ACTA 2026 (France)
- Biobetters: The Next Generation of Biologics - Biosimilars 2026 (France)
- Bioinformatics and Computational Approaches - ANALYTICA ACTA 2026 (France)
- Biomedical Biotechnology - Biotechnology 2025 (Spain)
- Biopharmaceuticals and Biologics - ANALYTICA ACTA 2026 (France)
- Biopharmaceuticals and Biosimilars - Biotechnology 2025 (Spain)
- Biosimilar Market Access and Reimbursement Policies - Biosimilars 2026 (France)
- Biosimilars in Oncology and Autoimmune Diseases - Biosimilars 2026 (France)
- Biosimilars in Rare and Orphan Diseases - Biosimilars 2026 (France)
- Biotechnology and Global Health - Biotechnology 2025 (Spain)
- Biotechnology in Agriculture - Biotechnology 2025 (Spain)
- Chemical Analysis and Sensing - ANALYTICA ACTA 2026 (France)
- Clinical and Forensic Analysis - ANALYTICA ACTA 2026 (France)
- Clinical Trials & Comparability Studies for Biosimilars - Biosimilars 2026 (France)
- Collaborative Models in Biosimilar Development - Biosimilars 2026 (France)
- Computational and Systems Biology - Biotechnology 2025 (Spain)
- Cost-Effectiveness and Health Economics of Biosimilars - Biosimilars 2026 (France)
- Data Integrity and Compliance in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Emerging Contaminants and Analytical Challenges - ANALYTICA ACTA 2026 (France)
- Emerging Trends in Analytical and Bioanalytical Techniques - ANALYTICA ACTA 2026 (France)
- Environmental Analysis - ANALYTICA ACTA 2026 (France)
- Environmental Biotechnology - Biotechnology 2025 (Spain)
- Evolving Trends and Innovations in Biosimilar Development and Access - Biosimilars 2026 (France)
- Food and Beverage Analysis - ANALYTICA ACTA 2026 (France)
- Formulation and Delivery Systems for Biologics - Biosimilars 2026 (France)
- Future Biotherapeutics: Cell and Gene Therapies - Biosimilars 2026 (France)
- Future of Monoclonal Antibodies and Fusion Proteins - Biosimilars 2026 (France)
- Future Trends in Biotechnology - Biotechnology 2025 (Spain)
- Genomics and Molecular Biology Analysis - ANALYTICA ACTA 2026 (France)
- Global Trends and Challenges in Biosimilar Adoption - Biosimilars 2026 (France)
- High-Resolution Techniques - ANALYTICA ACTA 2026 (France)
- Imaging Techniques and Microscopy - ANALYTICA ACTA 2026 (France)
- Immunogenicity Assessment and Risk Management - Biosimilars 2026 (France)
- Industrial Biotechnology - Biotechnology 2025 (Spain)
- Industrial Scale-Up and Bioprocessing - Biotechnology 2025 (Spain)
- Instrumentation and Automation in Analytical Chemistry - ANALYTICA ACTA 2026 (France)
- Interchangeability and Substitution Policies - Biosimilars 2026 (France)
- Manufacturing and Quality Control of Biosimilars - Biosimilars 2026 (France)
- Marine Biotechnology - Biotechnology 2025 (Spain)
- Metabolomics and Proteomics - ANALYTICA ACTA 2026 (France)
- Microbial Biotechnology - Biotechnology 2025 (Spain)
- Nanomaterials and Nanotechnology in Analysis - ANALYTICA ACTA 2026 (France)
- Patient and Physician Perspectives on Biosimilar Use - Biosimilars 2026 (France)
- Pharmaceutical Analysis - ANALYTICA ACTA 2026 (France)
- Pharmacovigilance and Post-Marketing Surveillance - Biosimilars 2026 (France)
- Quality by Design (QbD) in Analytical Method Development - ANALYTICA ACTA 2026 (France)
- Regenerative Medicine and Analytical Techniques - ANALYTICA ACTA 2026 (France)
- Regulatory Pathways and Global Harmonization - Biosimilars 2026 (France)
- Spectroscopic Techniques - ANALYTICA ACTA 2026 (France)
- Stem Cell and Regenerative Medicine - Biotechnology 2025 (Spain)
- Surface and Interface Analysis - ANALYTICA ACTA 2026 (France)
- Synthetic Biology and Bioengineering - Biotechnology 2025 (Spain)
- Vaccine Development and Immunotherapy - Biotechnology 2025 (Spain)
- Workshops and Hands-On Training - ANALYTICA ACTA 2026 (France)